Does Tamiflu Cause Dizziness?
Yes, dizziness is a documented adverse effect of oseltamivir (Tamiflu), though it occurs relatively infrequently and is generally mild.
Evidence from FDA Drug Labeling
According to the FDA-approved prescribing information, dizziness was reported in clinical trials of oseltamivir 1. In adult treatment studies, dizziness occurred in 2% of patients taking oseltamivir 75 mg twice daily compared to 3% in the placebo group 1. In prophylaxis studies, dizziness was reported in 1% of both oseltamivir and placebo groups 1.
The key finding is that dizziness occurred at similar or even lower rates in oseltamivir-treated patients compared to placebo, suggesting it may be related to influenza illness itself rather than the medication.
Clinical Context and Interpretation
The adverse event profile from multiple guidelines and FDA labeling consistently shows:
- Most common side effects are gastrointestinal: nausea (7-10%) and vomiting (2-9%) 1
- Dizziness is uncommon (1-2% incidence) and occurs at rates comparable to placebo 1
- The medication is generally well-tolerated, with less than 1% of patients discontinuing due to adverse events 1
Important Caveats
Distinguishing Drug Effect from Influenza Symptoms
Influenza itself commonly causes dizziness, headache, and neurologic symptoms 1. The similar incidence in placebo groups suggests that reported dizziness may often be attributable to the underlying viral illness rather than oseltamivir treatment.
Special Populations at Higher Risk
Patients with renal impairment may experience higher rates of side effects, including dizziness. One study in end-stage renal disease patients receiving prophylactic oseltamivir found dizziness in 9.1% of participants 2. Dose adjustment is required for creatinine clearance 10-30 mL/min 3, 4, 5.
Neuropsychiatric Events
While rare, oseltamivir has been associated with neuropsychiatric symptoms in postmarketing surveillance, particularly in pediatric patients 1. These can include delirium and abnormal behavior, though the contribution of oseltamivir versus influenza itself remains unclear 1. Older adults with dementia or renal disease may be particularly vulnerable 6.
Clinical Recommendations
- Counsel patients that mild dizziness may occur but is uncommon and typically related to influenza illness itself
- Monitor closely for neuropsychiatric symptoms, especially in children and older adults with cognitive impairment 1, 6
- Adjust dosing in patients with renal insufficiency to minimize adverse effects 3, 4, 5
- Taking with food may improve overall tolerability, particularly for gastrointestinal symptoms 1
The benefit of oseltamivir treatment in reducing mortality and complications in hospitalized patients outweighs the minimal risk of dizziness 7.